Comparison between Clinical Disabilities and Electrophysiological Values in Charcot-Marie-Tooth 1A Patients with PMP22 Duplication
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background and Purpose Charcot-Marie-Tooth disease (CMT) type 1A (CMT1A) is the demyelinating form of CMT that is significantly associated with PMP22 duplication. Some studies have found that the disease-related disabilities of these patients are correlated with their compound muscle action potentials (CMAPs), while others have suggested that they are related to the nerve conduction velocities. In the present study, we investigated the correlations between the disease-related disabilities and the electrophysiological values in a large cohort of Korean CMT1A patients. Methods We analyzed 167 CMT1A patients of Korean origin with PMP22 duplication using clinical and electrophysiological assessments, including the CMT neuropathy score and the functional disability scale. Results Clinical motor disabilities were significantly correlated with the CMAPs but not the motor nerve conduction velocities (MNCVs). Moreover, the observed sensory impairments matched the corresponding reductions in the sensory nerve action potentials (SNAPs) but not with slowing of the sensory nerve conduction velocities (SNCVs). In addition, CMAPs were strongly correlated with the disease duration but not with the age at onset. The terminal latency index did not differ between CMT1A patients and healthy controls. Conclusions In CMT1A patients, disease-related disabilities such as muscle wasting and sensory impairment were strongly correlated with CMAPs and SNAPs but not with the MNCVs or SNCVs. Therefore, we suggest that the clinical disabilities of CMT patients are determined by the extent of axonal dysfunction.
Abstract
Background and Purpose Charcot-Marie-Tooth disease (CMT) type 1A (CMT1A) is the demyelinating form of CMT that is significantly associated with PMP22 duplication. Some studies have found that the disease-related disabilities of these patients are correlated with their compound muscle action potentials (CMAPs), while others have suggested that they are related to the nerve conduction velocities. In the present study, we investigated the correlations between the disease-related disabilities and the electrophysiological values in a large cohort of Korean CMT1A patients. Methods We analyzed 167 CMT1A patients of Korean origin with PMP22 duplication using clinical and electrophysiological assessments, including the CMT neuropathy score and the functional disability scale. Results Clinical motor disabilities were significantly correlated with the CMAPs but not the motor nerve conduction velocities (MNCVs). Moreover, the observed sensory impairments matched the corresponding reductions in the sensory nerve action potentials (SNAPs) but not with slowing of the sensory nerve conduction velocities (SNCVs). In addition, CMAPs were strongly correlated with the disease duration but not with the age at onset. The terminal latency index did not differ between CMT1A patients and healthy controls. Conclusions In CMT1A patients, disease-related disabilities such as muscle wasting and sensory impairment were strongly correlated with CMAPs and SNAPs but not with the MNCVs or SNCVs. Therefore, we suggest that the clinical disabilities of CMT patients are determined by the extent of axonal dysfunction.
참고문헌 (29)
- Lupski JR, "DNA duplication associated with Charcot-Marie-Tooth disease type 1A", Cell, 66, pp.219~232 (1991)
- 최병옥, "Mutational analysis of PMP22, MPZ, GJB1, EGR2 and NEFL in Korean Charcot-Marie-Tooth neuropathy patients.", Human mutation, 24(2), pp.185~186, John Wiley & Sons Inc.
- Zhang F, "Mechanisms for nonrecurrent genomic rearrangements associated with CMT1A or HNPP: rare CNVs as a cause for missing heritability", Am J Hum Genet, 86, pp.892~903 (2010)
- Roa BB, "Charcot-Marie-Tooth disease type 1A. Association with a spontaneous point mutation in the PMP22 gene", N Engl J Med, 329, pp.96~101 (1993)
- Shy ME, "Neuropathy progression in Charcot-Marie-Tooth disease type", Neurology, 70, pp.378~383 (2008)
- Krajewski KM, "Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A", Brain, 123, pp.1516~1527 (2000)
- Low PA, "Hereditary demyelinating neuropathy in the trembler mouse", J Neurol Sci, 26, pp.565~574 (1975)
- Sancho S, "Distal axonopathy in peripheral nerves of PMP22-mutant mice", Brain, 122, pp.1563~1577 (1999)
- Hattori N, "Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients", Brain, 126, pp.134~151 (2003)
- Dyck PJ, "Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. II. Neurologic, genetic, and electrophysiologic findings in various neuronal degenerations", Arch Neurol, 18, pp.619~625 (1968)
- Harding AE, "The clinical features of hereditary motor and sensory neuropathy types I and II", Brain, 103, pp.259~280 (1980)
- Bouché P, "Peroneal muscular atrophy. Part 1. Clinical and electrophysiological study", J Neurol Sci, 61, pp.389~399 (1983)
- Birouk N, "Charcot-Marie-Tooth disease type 1A with 17p11.2 duplication. Clinical and electrophysiological phenotype study and factors influencing disease severity in 119 cases", Brain, 120, pp.813~823 (1997)
- Hoogendijk JE, "Ongerboer de Visser BW. Hereditary motor and sensory neuropathy type I: clinical and neurographical features of the 17p duplication subtype", Muscle Nerve, 17, pp.85~90 (1994)
- Thomas PK, "The phenotypic manifestations of chromosome 17p11.2 duplication", Brain, 120, pp.465~478 (1997)
- Lewis RA, "Electrophysiological features of inherited demyelinating neuropathies: A reappraisal in the era of molecular diagnosis", Muscle Nerve, 23, pp.1472~1487 (2000)
- Shy ME, "Reliability and validity of the CMT neuropathy score as a measure of disability", Neurology, 64, pp.1209~1214 (2005)
- Chung KW, "Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations", BRAIN, 129, pp.2103~2118
- Pareyson D, "Clinical and electrophysiological aspects of Charcot-Marie-Tooth disease", Neuromolecular Med, 8, pp.3~22 (2006)
- Videler AJ, "Motor axon loss is associated with hand dysfunction in Charcot-Marie-Tooth disease 1a", Neurology, 71, pp.1254~1260 (2008)
- Verhamme C, "Clinical disease severity and axonal dysfunction in hereditary motor and sensory neuropathy Ia", J Neurol, 251, pp.1491~1497 (2004)
- de Waegh S, "Altered slow axonal transport and regeneration in a myelin-deficient mutant mouse: the trembler as an in vivo model for Schwann cell-axon interactions", J Neurosci, 10, pp.1855~1865 (1990)
- de Waegh SM, "Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells", Cell, 68, pp.451~463 (1992)
- Sahenk Z, "Effects of PMP22 duplication and deletions on the axonal cytoskeleton", Ann Neurol, 45, pp.16~24 (1999)
- Watson DF, "Altered neurofilament phosphorylation and beta tubulin isotypes in Charcot-Marie-Tooth disease type 1", Neurology, 44, pp.2383~2387 (1994)
- Killian JM, "Longitudinal studies of the duplication form of Charcot-Marie-Tooth polyneuropathy", Muscle Nerve, 19, pp.74~78 (1996)
- Pareyson D, "Hereditary predominantly motor neuropathies", Curr Opin Neurol, 22, pp.451~459 (2009)
- Pareyson D, "Diagnosis, natural history, and management of Charcot-Marie-Tooth disease", Lancet Neurol, 8, pp.654~667 (2009)
- Roy EP 3rd, "Longitudinal conduction studies in hereditary motor and sensory neuropathy type 1", Muscle Nerve, 12, pp.52~55 (1989)